BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17428240)

  • 1. Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma.
    Klatte T; Böhm M; Nelius T; Filleur S; Reiher F; Allhoff EP
    BJU Int; 2007 Jul; 100(1):209-14. PubMed ID: 17428240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
    Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
    Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
    Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
    ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
    Song SH; Jeong IG; You D; Hong JH; Hong B; Song C; Jung WY; Cho YM; Ahn H; Kim CS
    Int J Clin Exp Pathol; 2014; 7(11):7681-9. PubMed ID: 25550804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
    Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
    Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
    Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
    Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
    Alamdari FI; Rasmuson T; Grankvist K; Ljungberg B
    Scand J Urol Nephrol; 2007; 41(1):5-9. PubMed ID: 17366095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
    Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
    Eur J Cancer Prev; 2002 Jun; 11(3):245-52. PubMed ID: 12131658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.
    Sato K; Tsuchiya N; Sasaki R; Shimoda N; Satoh S; Ogawa O; Kato T
    Jpn J Cancer Res; 1999 Aug; 90(8):874-9. PubMed ID: 10543260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
    Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
    Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
    Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
    Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.
    Qi L; Du J; Zhang Z; Diao L; Chen X; Yao X
    BJU Int; 2013 Aug; 112(4):E415-23. PubMed ID: 23879920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
    Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
    Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
    Jacobsen J; Rasmuson T; Grankvist K; Ljungberg B
    J Urol; 2000 Jan; 163(1):343-7. PubMed ID: 10604387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
    Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
    J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factors in plasma of brain tumour patients.
    Ilhan A; Gartner W; Neziri D; Czech T; Base W; Hörl WH; Wagner L
    Anticancer Res; 2009 Feb; 29(2):731-6. PubMed ID: 19331229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses.
    Cenni E; Savarino L; Antonioli D; Pellacani A; Giunti A; Baldini N
    Acta Orthop; 2005 Feb; 76(1):61-6. PubMed ID: 15788309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
    Hu Y; Hu MM; Shi GL; Han Y; Li BL
    Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor BB modulates PCNA protein synthesis partially through the transforming growth factor beta signalling pathway in vascular smooth muscle cells.
    Pan D; Yang J; Lu F; Xu D; Zhou L; Shi A; Cao K
    Biochem Cell Biol; 2007 Oct; 85(5):606-15. PubMed ID: 17901902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.